HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Reaction

Formaldehyde → (R)-tert-butyl 3-(hydroxymethyl)-4-methylpiperazine-1-carboxylate

HRID 60250
Print

Reaction equation

HRID 60250 reaction equation
[OH:1][CH2:2][C@@H:3]1[NH:8][CH2:7][CH2:6][N:5]([C:9]([O:11][C:12]([CH3:15])([CH3:14])[CH3:13])=[O:10])[CH2:4]1.C=O.[C:18](O[BH-](OC(=O)C)OC(=O)C)(=O)C.[Na+].C(=O)([O-])[O-].[Na+].[Na+]>C(#N)C.O.C(Cl)Cl.CO>[OH:1][CH2:2][C@@H:3]1[N:8]([CH3:18])[CH2:7][CH2:6][N:5]([C:9]([O:11][C:12]([CH3:15])([CH3:14])[CH3:13])=[O:10])[CH2:4]1
ParticipantsProcedureWorkupSources & evidenceReaction notes

Participants

9

Reactant 4

HCID 712FormaldehydeHCID 10340Sodium CarbonateHCID 5049666Sodium triacetoxyborohydrideHCID 24820286tert-Butyl (3R)-3-(hydroxymethyl)piperazine-1-carboxylate

Product 1

HCID 58365052(R)-tert-butyl 3-(hydroxymethyl)-4-methylpiperazine-1-carboxylate

Reagents, catalysts & solvents 4

HCID 887
Methanol
Solvent
HCID 962WaterSolvent
HCID 6342AcetonitrileSolvent
HCID 6344DichloromethaneSolvent

Procedure

To a solution of (R)-tert-butyl 3-(hydroxymethyl)piperazine-1-carboxylate (115 mg, 0.53 mmol) in acetonitrile (1.4 mL) and water (0.3 mL) was added Formalin (0.11 mL, 1.6 mmol) followed by sodium triacetoxyborohydride (225 mg, 1.1 mmol). The reaction mixture was stirred for 20 minutes at ambient temperature. The reaction mixture was then basified via the addition of saturated aqueous sodium carbonate solution (1 mL), diluted with methylene chloride (50 mL) and methanol (5 mL), and washed with saturated aqueous sodium bicarbonate solution (2×15 mL). The organic layer was separated, dried over sodium sulfate, and concentrated in vacuo to afford a white crystalline solid, which was used in the next step without any further purification (120 mg, 98%).

Workup

  1. washwashed with saturated aqueous sodium bicarbonate solution (2×15 mL)
  2. customThe organic layer was separated
  3. dry with materialdried over sodium sulfate
  4. concentrationconcentrated in vacuo
  5. customto afford a white crystalline solid, which
  6. customwas used in the next step without any further purification (120 mg, 98%)

Sources & evidence

ORD record
ord-209d4574534a4c8dbaebce40c777f396
Source dataset
uspto-grants-2016_09
DOI
10.6084/m9.figshare.5104873.v1
Patent number
US09440976B2

Reaction notes

On this pageParticipantsProcedureWorkupSources & evidenceReaction notes